GLAND PHARMA
Back to All Ratios
|
GLAND PHARMA Last 5 Year EBIT Growth History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EBIT Growth(%) | 35.59 | -4.67 | 9.11 | -34.60 | 21.34 |
What is the latest EBIT Growth ratio of GLAND PHARMA ?
| Year | EBIT Growth |
|---|---|
| Mar2026 | 35.59 |
| Mar2025 | -4.67 |
| Mar2024 | 9.11 |
| Mar2023 | -34.60 |
| Mar2022 | 21.34 |
How is EBIT Growth of GLAND PHARMA Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2026 | 35.59 | Positive | |
| Mar2025 | -4.67 | Negative | |
| Mar2024 | 9.11 | Positive | |
| Mar2023 | -34.6 | Negative | |
| Mar2022 | 21.34 | - | |
Other Financial Ratios of GLAND PHARMA
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹42,525.5 Cr | 3.2% | 2.4% | 24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 3.2% |
2.4% |
24.7% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses